Blood Neoplasia Oncology

Alternative oncogenic drivers and sensitivity to BTK inhibition in CRISPR/Cas gene-edited human DLBCL cell models

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →